biomedicina slovenica

pr=Čufer : 301-400

  1. Lahajnar Slavica; Čufer Tanja
    Vprašanja in odgovori
    2006 ►
  2. Borštnar Simona; Čufer Tanja
    Zdravljenje hormonsko neodvisnega raka prostate
    2006 ►
  3. Čufer Tanja
    Intervju s prof. dr. Marijo Us-Krašovec: strokovnjakinjo, znanstvenico in pedagoginjo, idejno materjo časopisa Onkologija
    2006 ►
  4. Hočevar Marko; Vakselj Aleš; Čufer Tanja; Us Jurij
    Vprašanja in odgovori
    2005 ►
  5. Čufer Tanja; Borštnar Simona; Vrhovec Ivan
    Prognostic and predictive value of the urokinase-type plasminogen activator (UPA) and its inhibitor PAI-1 in operable breast cancer
    2003 ►
  6. Reberšek Martina; Čufer Tanja; Serša Gregor
    Electrochemotherapy (ECT) with intratumoral application of cisplatin in breast cancer
    2003 ►
  7. Južnič-Šetina Tanja; Čufer Tanja; Borštnar Simona
    Breast cancer in men: a 20 year review of 60 patients in Slovenia
    2003 ►
  8. Čufer Tanja; Pajk Bojana; Borštnar Simona
    Individualised systemic treatment
    2006 ►
  9. Pajk Bojana; Čufer Tanja; Canney Peter; Ellis Paul; Cameron David; Blot Emmanuel; Vermorken Jan; Coleman Robert; Marreaud Sandrine; Bogaerts Jan
    Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from EORTC 10001 randomized phase II trial
    2008 ►
  10. Čufer Tanja
    Pomen kliničnih raziskav v onkologiji
    2008 ►
  11. Vojaković Ksenija; Čufer Tanja
    3. dan internistične onkologije, oktober 2007
    2008 ►
  12. Bizjak-Ogrinc Urška; Čufer Tanja; Pompe-Kirn Vera
    Survival of patients with invasive urinary bladder cancer in Slovenia regarding to stage of disease and treatment in years 1987-1997
    2007 ►
  13. Buturović-Ponikvar J; Adamlje T; Blamuša D; Ceglar Z; Cimerman-Steklasa S; Černe S; Čufer A; Drozg A; Ekart R; Guček A; Kandus A; Kapun S; Kralj-Lapert S; Kralj S; Malovrh M; Močivnik M; Novljan G; Ponikvar R; Rukavina N; Rus I; Saksida S; Vujkovac B
    Hemodialysis in Slovenia
    2008 ►
  14. Ravnik Maja; Takač Iztok; Arko Darja; Gorišek Borut; Čas-Sikošek Nina; Lampelj Maja; Ravnik Janez; Čufer Tanja
    Expression of invasive markers (uPA/PAI-1) in four different HER2, ER, PR subgroups of early breast cancer
    2008 ►
  15. Lahajnar Slavica; Krčevski-Škvarč Nevenka; Stepanović Aleksander; Čufer Tanja
    Usmeritve za zdravljenje bolečine pri odraslem bolniku z rakom
    [Guidance for cancer pain treatment in adult patients]
    2008 ►
  16. Zielinski Christoph C.; Awada Ahmad; Cameron David A.; Čufer Tanja; Martin Miguel; Aapro Matti S.
    The impact of new European organisation for research and treatment of cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients
    2008 ►
  17. Čufer Tanja
    Reducing the risk of late recurrence in hormone-responsive breast cancer
    2007 ►
  18. Snoj Nataša; Čufer Tanja
    Biološko in tarčno zdravljenje karcinomov
    2007 ►
  19. Matos Erika; Čufer Tanja; Žgajnar Janez; Bračko Matej; Takač Iztok
    Lastnosti tumorja in zdravljenje
    2007 ►
  20. Čufer Tanja
    Rak prostate
    2006 ►
  21. Čufer Tanja
    Sistemsko zdravljenje raka: dejstva in pričakovanja
    2007 ►
  22. Cataliotti L.; Čufer Tanja
    Guidelines on the standards for the training of specialised health professionals dealing with breast cancer
    2007 ►
  23. Čufer Tanja
    New standards in the chemotherapy of breast cancer
    2006 ►
  24. Čufer Tanja
    Sistemsko zdraveljenje raka: dejstva in pričakovanja
    [Systemic theapy of cancer: facts and expectations]
    2007 ►
  25. Matos Erika; Čufer Tanja
    Adjuvant treatment of breast cancer patients with trastuzumab
    [Dopolnilno zdravljenje bolnic z rakom dojke s transtuzumabom]
    2007 ►
  26. Borštnar Simona; Čufer Tanja; Kmetec Andrej; Kragelj Borut; Ovčak Zdenka; Sedmak Boris; Milakić-Snoj Zvezdana; Volavšek Metka; Primic-Žakelj Maja
    Rak prostate: kaj morate vedeti
    2007 ►
  27. Čufer T
    The advantages and shortages of academic research in Europe
    2007 ►
  28. Ravnik M; Arko D; Žagar T; Primic-Žakelj M; Čufer T
    Breast cancer and second malignancies
    2007 ►
  29. Matos E; Čufer T
    The role of trastuzumab in the adjuvant setting
    2007 ►
  30. Čufer T
    The role of chemotherapy in early breast cancer patients
    2007 ►
  31. Morales Leilani; Čufer Tanja
    Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer : a randomised phase III trial of the European Organis[!]ation for Research and Treatment of Cancer Breast Group
    2007 ►
  32. Buturović-Ponikvar Jadranka; Adamlje T; Blanuša D; Ceglar Z; Cimerman-Steklasa S; Černe S; Čufer A; Drozg A; Ekart R; Guček A; Kandus A; Kapun S; Kralj-Lopert S; Kralj S; Malovrh M; Močivnik M; Novljan G; Ponikvar R; Rukavina N; Rus I; Saksida S; Vujkovac B
    Vascular access in chronic hemodialysis patients in Slovenia: data from the Slovenian renal replacement therapy registry, annual report 2005
    2007 ►
  33. Borštnar Simona; Pajk Bojana; Bernot Marjana; Čufer Tanja; Horvat Marika; Mlakar-Mastnak Denis; Ocvirk janja; Sonc Monika; Umičevič Snežana; Uršič-Vrščaj Marjetka; Zajc Metka; Zakotnik Branko
    Napotki za premagovanje neželenih učinkov sistemskega zdravljenja raka
    2007 ►
  34. Čufer Tanja; Pajk Bojana
    Sistemska terapija rakave bolezni in njen vpliv na bolnika
    2007 ►
  35. Čufer Tanja
    Biološko zdravljenje karcinomov
    [Update on the biological therapy of carcinomas]
    2007 ►
  36. Tomažič Janez; Vovk Marjeta; Čufer Tanja; Tomšič Matija; Pretnar Jože
    Okužbe pri zdravljenju z biološkimi zdravili
    [Infections in biological treatment]
    2007 ►
  37. Virant Igor; Sonc Monika; Čufer Tanja
    Farmakologija protitumornih učinkovin s poudarkom na interakcijah
    2007 ►
  38. Čufer Tanja; Snoj Nataša
    Biološka terapija karcinomov
    2007 ►
  39. Matos E; Pajk B; Borštnar S; Čufer T
    Dopolnilno zdravljenje bolnic z rakom dojke s trastuzumabom; trenutno priporočeni izbor zdravljanja na Onkološkem inštitutu v Ljubljani
    2006 ►
  40. Borštnar S; Pajk B; Matos E; Čufer T
    Dopolnilno hormonsko zdravljenje pomenopavznih bolnic s hormonsko odvisnim rakom dojke; trenutno priporočeni izbor zdravljenja na Onkološkem inštitutu v Ljubljani
    2006 ►
  41. Čufer Tanja
    Nova zdravila za boljše obvladovanje raka dojk
    2006 ►
  42. Čufer Tanja; Snoj Nataša
    Algoritmi zdravljenja raka dojke in novosti na tem področju
    [Treatment algorithms for breast cancer and new approaches]
    2006 ►
  43. Globokar T; Snoj Nataša; Sadikov A; Čufer T
    Amenorrhea as a prognostic factor in premenopausal endocrine responsive early breast cancer patients
    2006 ►
  44. Snoj Nataša; Globokar T; Sadikov A; Čufer T
    Correlation between hormonal receptor levels and efficacy of hormonal therapy and chemotherapy in metastatic breast cancer
    2006 ►
  45. Čufer Tanja
    Novo zdravilo?
    2006 ►
  46. Foekens John A; Atkins David; Zhang Yi; Sweep Fred CGJ; Harbeck Nadia; Paradiso Angelo; Čufer Tanja; Sieuwerts Anieta M; Talantov Dmitri; Golouh Rastko
    Multicenter validation of a gene expression-based prognostic signature in lymph node - negative primary breast cancer
    2006 ►
  47. Čufer Tanja
    Sistemsko zdravljenje
    2006 ►
  48. Decock Julie; Paradaens Robert; Čufer Tanja
    Proteases and metastasis: clinical relevance nowadays?
    2005 ►
  49. Čufer Tanja
    Uspešna dopolnilna zdravila
    2005 ►
  50. Kozak Matija; Čufer Tanja
    Presejalne preiskave za odkrivanje raka pri bolnikih z vensko trombozo
    2006 ►
  51. Červek Jožica; Čufer Tanja; Uršič-Vrščaj Marjetka; Zakotnik Branko
    Le ovinek na poti življenja: knjižica za pomoč bolnikom z rakom in njihovim svojcem
    2006 ►
  52. Čufer Tanja
    Chemotherapy in the adjuvant setting: goals and strategies
    2005 ►
  53. Piccart MJ; de Valeriola D; Dal-Lago L; de Azambuja E; Demonty G; Lebrun F; Bernard-Marty Ch; Colozza M; Čufer T
    Adjuvant chemotherapy in 2005: standards and beyond
    2005 ►
  54. Čufer Tanja
    Biology of metastasis with focus on proteases
    2004 ►
  55. Čufer T; Vrdoljak E
    Sign: a Phase II, open-label, randomized study comparing gefitinib (IRESSA) with docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer
    2005 ►
  56. Snoj Nataša; Drev Primož; Golouh Rastko; Čufer Tanja
    The response to treatment with anastrozole and tamoxifen in HER2 positive breast cancer patients
    2005 ►
  57. Ebert Maja; Borštnar Simona; Červek Jožica; Čufer Tanja; Pajk Bojana
    Feasibility and toxicity of adjuvant chemotherapy in breast cancer patients over 70 years old
    2005 ►
  58. Globokar Tina; Borštnar Simona; Čufer Tanja; Pajk Bojana; Červek Jožica
    CNS metastases in breast cancer patients treated with trastuzumab
    2005 ►
  59. Čufer T; Vrdoljak E
    Results from a phase II, open-label, randomized study (SIGN) comparing gefitinib with docetaxel as second-line theraphy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer
    2005 ►
  60. Harbeck N; Bohlmann I; Ross JS; Gruetzman R; Kristiansen G; Margossian A; Hartmann A; Čufer T; Paradiso A; Maier S
    Multicenter study validates PITX2 DNA methylation for risk prediction in tamoxifen-treated, none-negative breast cancer using paraffin-embedded tumor tissue
    2005 ►
  61. Lahajnar S; Rotovnik-Kozjek N; Čufer T; Vakselj A
    Vprašanja in odgovori
    2005 ►
  62. Čufer Tanja
    Rak ledvic
    2005 ►
  63. Čufer Tanja
    Rak prostate zbuja novo upanje
    2005 ►
  64. Čufer Tanja
    Palliative and supportive care
    2005 ►
  65. Čufer Tanja
    Hormoni in rak
    2005 ►
  66. Čufer T; Piccart-Gebhart M
    Adjuvant chemotherapy: standards and beyond
    2005 ►
  67. Jagodic M; Vrhovec I; Borštnar S; Čufer T
    Prognostic and predictive value of cathepsins D and L in operable breast cancer patients
    2005 ►
  68. Čufer Tanja
    Clinical relevance of proteases and their inhibitors in breast cancer
    2005 ►
  69. Kragelj Borut; Zaletel-Kragelj Lijana; Sedmak Boris; Čufer Tanja; Červek Jožica
    Phase II study of radiochemotherapy with vinblastine in invasive bladder cancer
    2005 ►
  70. Čufer T
    Citostatsko zdravljenje napredovalega raka prostate
    2005 ►
  71. Čufer Tanja
    Stanje splošne oslabelosti pri bolnikih z rakom
    2005 ►
  72. Čufer Tanja
    Prognoza netipljivih invazivnih rakov dojke
    2004 ►
  73. Borštnar S; Vrhovec I; Čufer T
    High levels of uPA and PAI-1 predicts a good response to antracyclines
    2004 ►
  74. Čufer Tanja
    Rak prostate: nejasnosti in pasti odkrivanja
    2004 ►
  75. Čufer Tanja
    Hormonsko zdravljenje invazivnega raka dojk
    2004 ►
  76. Efficace Fabio; Therasse Patrick; Piccart Martine J; Coens Corneel; van Steen Kristel; Welnicka-Jaskiewicz Marzena; Čufer Tanja; Dyczka Jaroslaw; Lichinitser Michail; Shepherd Lois
    Health-related quality of life parameters as prognostic factors in a nonmestatic breast cancer population: an international multicenter study
    2004 ►
  77. Globokar Tina; Pajk Bojana; Čufer Tanja
    Docetaxel chemotherapy induced amenorrhea in breast cancer patients
    2004 ►
  78. Snoj Nataša; Drev Primož; Pajk Bojana; Borštnar Simona; Golouh Rastko; Čufer Tanja
    The response to treatment with anastrozole in HER2 positive metastatic breast cancer patients
    2004 ►
  79. Piškur Peter; Sonc Monika; Čufer Tanja; Borštnar Simona; Mrhar Aleš
    Pharmacoeconomic aspects of adjuvant early breast cancer (EBC) treatment in postmenopausal women with anastrozole (A) or tamoxifen (T): Slovenian perspective
    2004 ►
  80. Velepič Marina; Čufer Tanja
    Sprejem in bivanje na Onkološkem inštitutu v Ljubljani
    2002 ►
  81. Efficace F; Therasse P; Piccart M; Coens C; Van Steen K; Welnicka-Jaskiewicz M; Čufer T; Lichinitser M; Shepherd L; Bottomley A
    Predicting survival with health-related quality of life scores in locally advanced breast cancer: results from an international randomized controlled trial
    2004 ►
  82. Paridaens R; Therasse P; Dirix L; Beex L; Piccart M; Cameron D; Čufer T; Roozendaal K; Nooij M; Mattiacci M-R
    First line hormonal treatment (HT) for metastatic breast cancer (MBC) with exemestane (E) or tamoxifen (T) in postmenopausal patients (pts) - A randomized phase III trial of the EORTC breast group
    2004 ►
  83. Bottomley Andrew; Biganzoli Laura; Čufer Tanja; Coleman Robert E; Coens Cornel; Efficace Fabio; Calvert Hilary Allan; Gamucci Teresa; Twelves Chris; Fargeot Pierre; Piccart Martine
    Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European organization for research and treatment of cancer breast cancer group, Investigational drug branch for breast cancer and the New drug development group study
    2004 ►
  84. Kocijančič I; Kocijančič K; Čufer T
    Imaging of pleural fluid in healthy individuals
    2004 ►
  85. Reberšek Martina; Čufer Tanja; Čemažar Maja; Kranjc Simona; Serša Gregor
    Electrochemotherapy with cisplatin of cutaneous tumor lesions in breast cancer
    2004 ►
  86. Pajk B; Borštnar S; Snoj Nataša; Čufer T
    Tumorske značilnosti in preživetje brez znamenj bolezni (PBZB) bolnic z rakom dojke starejših od 70 let v primerjavi z mlajšimi bolnicami
    2004 ►
  87. Borštnar Simona; Čufer Tanja; Pajk Bojana
    Rak dojke: kaj morate vedeti
    2004 ►
  88. Atalay G; Dirix L; Biganzoli L; Beex L; Nooij M; Cameron D; Lohrisch C; Čufer T; Lobelle JP; Mattiaci MR
    The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'
    2004 ►
  89. Piškur Peter; Sonc Monika; Čufer Tanja; Borštnar Simona; Mrhar Aleš
    Pharmacoeconomic aspects of adjuvant early breast cancer (EBC) treatment in postmenopausal women with anastrozole (A) or tamoxifen (T): Slovenian perspective
    2004 ►
  90. Look Maxime; van Putten Vim; Duffy Michael; Harbeck Nadia; Christensen Ib Jarle; Thomssen Christoph; Kates Ronald; Spyratos Frederique; Čufer Tanja; Borštnar Simona
    Pooled analysis of prognostic impact of uPA and PAI-I in breast cancer patients
    2003 ►
  91. Paridaens R; Therasse P; Dirix L; Beex L; Piccart MJ; Cameron D; Čufer T; Roozendael K; Nooy M; Mattiacci MR
    First results of a randomized phase III trial comparing exemestane versus tamoxifen as first-line hormone therapy (HT) for postmenopausal women with metastatic breast cancer (MBC) - EORTC 10951 in collaboration with the exemestane working group and NCIC clinical trials group
    2004 ►
  92. Matos E; Borstnar S; Vrhovec I; Svetič B; Čufer T
    PAI-1 and PAI-2 as predictive factors in breast cancer
    2004 ►
  93. Drev P; Golouh R; Snoj Nataša; Čufer T
    Correlation between Her-2 status in primary tumour and response to anastrozole in patients with metastatic breast cancer
    2004 ►
  94. Pajk B; Borštnar S; Snoj Nataša; Čufer T
    Disease free survival (DFS) in breast cancer patients older than 70 years compered to younger patients groups
    2004 ►
  95. Paridaens R; Dyczka J; Rutgers EJT; Coleman R; Čufer T; Jassem J; Nortier JRW; Morales L; Mattiacci MR; Therasse P; Gasthuisberg UZ
    Postoperative adjuvant chemotherapy folowed by adjuvant tamoxifen versus nil for patients with operable breast cancer. First results of a randomized phase III trial EORTC 10901
    2004 ►
  96. Snoj Nataša; Pajk B; Borštnar S; Čufer T
    The benefits of adjuvant hormonal therapy in patients with early breast cancer 35 years old or younger
    2004 ►
  97. Piškur P; Sonc M; Čufer T; Borštnar S; Mrhar A
    Pharmacoeconomics aspects of adjuvant early breast cancer treatment in postmenopausal women with anastrozole or tamoxifen: a Slovenian perspective
    2004 ►
  98. Čufer Tanja
    Generična in medsebojno zamenljiva zdravila v onkologiji
    2003 ►
  99. Čufer Tanja
    Biološko zdravljenje
    2004 ►
  100. Čufer Tanja
    Bolniku vedno povedati resnico
    2004 ►

   1 101 201 301 401 501  

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics